resveratrol has been researched along with Muscle Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 4 (57.14) | 2.80 |
Authors | Studies |
---|---|
Laforêt, P; Løkken, N; Madsen, KL; Nadaj-Pakleza, A; Storgaard, JH; Tard, C; van Hall, G; Vissing, J; Voermans, NC; Ørngreen, MC | 1 |
Aboulhoda, BE; Ghoweba, RE; Khowailed, AA; Rashed, LA; Selmy, A | 1 |
Callahan, LA; Schroder, EA; Supinski, GS | 1 |
Baartscheer, A; Bezzina, CR; Bleeker, JC; Coronel, R; Ferdinandusse, S; Guan, K; Houtkooper, RH; IJlst, L; Knottnerus, SJG; Li, W; Luo, X; Mengarelli, I; Portero, VM; Ulbricht, Y; Verkerk, AO; Visser, G; Wanders, RJA; Wijburg, FA; Wüst, RCI | 1 |
Allan, R; Coxon, CR; Deane, CS; Dugdale, HF; Hughes, DC; Morton, JP; Sharples, AP; Stewart, CE | 1 |
Bastin, J; Djouadi, F | 1 |
Chen, JK; Chen, KH; Cheng, ML; Chiu, DT; Jing, YH; Shiao, MS | 1 |
2 review(s) available for resveratrol and Muscle Disorders
Article | Year |
---|---|
Mitochondria and Critical Illness.
Topics: Acute Lung Injury; Alarmins; Antioxidants; Cesium; Critical Illness; DNA, Mitochondrial; Humans; Melatonin; Mitochondria; Muscle, Skeletal; Muscular Diseases; Organelle Biogenesis; Resveratrol; Sepsis | 2020 |
Resveratrol and Myopathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Energy Metabolism; Gene Expression Regulation; Humans; Muscular Diseases; Resveratrol; Stilbenes | 2016 |
1 trial(s) available for resveratrol and Muscle Disorders
Article | Year |
---|---|
No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross-over trial.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Carnitine O-Palmitoyltransferase; Congenital Bone Marrow Failure Syndromes; Cross-Over Studies; Exercise Tolerance; Fatty Acids; Humans; Lipid Metabolism, Inborn Errors; Metabolism, Inborn Errors; Mitochondrial Diseases; Muscular Diseases; Oxidation-Reduction; Resveratrol | 2022 |
4 other study(ies) available for resveratrol and Muscle Disorders
Article | Year |
---|---|
Synergistic role of resveratrol and exercise training in management of diabetic neuropathy and myopathy via SIRT1/NGF/GAP43 linkage.
Topics: Calcitonin Gene-Related Peptide; Diabetes Complications; Diabetic Neuropathies; Exercise; GAP-43 Protein; Male; Muscular Diseases; Nerve Growth Factor; Rats; Resveratrol; Sirtuin 1; Tumor Necrosis Factor-alpha | 2023 |
Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.
Topics: Action Potentials; Acyl-CoA Dehydrogenase, Long-Chain; Arrhythmias, Cardiac; Cardiac Electrophysiology; Congenital Bone Marrow Failure Syndromes; Epoxy Compounds; Fatty Acids; Humans; Induced Pluripotent Stem Cells; Lipid Metabolism, Inborn Errors; Mitochondria; Mitochondrial Diseases; Muscular Diseases; Myocytes, Cardiac; Oxidation-Reduction; Resveratrol | 2020 |
The role of resveratrol on skeletal muscle cell differentiation and myotube hypertrophy during glucose restriction.
Topics: Animals; Cell Differentiation; Cell Line; Glucose; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Diseases; Myoblasts, Skeletal; Resveratrol; Stilbenes | 2018 |
Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats.
Topics: Adenylate Kinase; Animals; Antioxidants; Cytokines; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Male; Metabolic Diseases; Models, Biological; Muscle, Skeletal; Muscular Diseases; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin; Wasting Syndrome | 2011 |